Evidence map›Paper›PMID 21159751›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2011

Allosteric modulation of related ligand-gated ion channels synergistically induces long-term potentiation in the hippocampus and enhances cognition.

Timothy B Johnstone, Zhenglin Gu, Ryan F Yoshimura, Anne-Sophie Villegier, Derk J Hogenkamp, Edward R Whittemore, Jin-Cheng Huang, Minhtam B Tran, James D Belluzzi, Jerrel L Yakel and 1 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Timothy B JohnstoneDepartment of Pharmacology, School of Medicine, University of California, Irvine, California, USA. tbjohnst@uci.edu
Zhenglin Gu
Ryan F Yoshimura
Anne-Sophie Villegier
Derk J Hogenkamp
Edward R Whittemore
Jin-Cheng Huang
Minhtam B Tran
James D Belluzzi
Jerrel L Yakel
Kelvin W Gee
National Institute of Environmental Health Sciences · USUniversity of California, Irvine · US

Funding

Modulation Of Neuronal Channels and Receptors in the BrainZIAES090089 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI YAKEL, JERREL L · 2009 to 2025
$42.2M
Development of Dual GABAA and alpah7 Nicotinic Receptor Modulators for ADU01AG032972 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI GEE, KELVIN W. · 2009 to 2013
$2.4M
Dual Allosteric Modulators of GABA-A and Nicotinic Receptors for Alzheimer's DiseR21AG028800 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI GEE, KELVIN W. · 2006 to 2007
$352k
Intramural NIH HHSNIA NIH HHS AG028800NIA NIH HHS AG032972NIA NIH HHS R21 AG028800NIA NIH HHS U01 AG032972
6 · The paper itself

Abstract

α5 Subunit-containing GABA(A) receptors (GABA(A)Rs) and α7 neuronal nicotinic-acetylcholine receptors (nAChRs) are members of the Cys-loop family of ligand-gated ion channels (LGICs) that mediate cognitive and attentional processes in the hippocampus. α5 GABA(A)Rs alter network activity by tonic inhibition of CA1/CA3 pyramidal cells of the hippocampus. Postsynaptic α7 nAChRs in the hippocampus regulate inhibitory GABAergic interneuron activity required for synchronization of pyramidal neurons in the CA1, whereas presynaptic α7 nAChRs regulate glutamate release. Can simultaneous allosteric modulation of these LGICs produce synergistic effects on cognition? We show that combined transient application of two allosteric modulators that individually 1) inhibit α5 GABA(A)Rs and 2) enhance α7 nAChRs causes long-term potentiation (LTP) of mossy fiber stimulation-induced excitatory postsynaptic currents (EPSC) from CA1 pyramidal neurons of rat hippocampal slices. The LTP effect evoked by two compounds is replicated by 3-(2,5-difluorophenyl)-6-(N-ethylindol-5-yl)-1,2,4-triazolo[4,3-b]pyridazine (522-054), a compound we designed to simultaneously inhibit α5 GABA(A)Rs and enhance α7 nAChRs. Selective antagonists for either receptor block sustained EPSC potentiation produced by 522-054. In vivo, 522-054 enhances performance in the radial arm maze and facilitates attentional states in the five-choice serial reaction time trial with similar receptor antagonist sensitivity. These observations may translate into therapeutic utility of dual action compounds in diseases of hippocampal-based cognitive impairment.

Indexed as

Allosteric Regulationalpha7 Nicotinic Acetylcholine ReceptorAnimalsCognitionFemaleHippocampusIndolesLigand-Gated Ion ChannelsLong-Term PotentiationMaleRatsRats, Sprague-DawleyRats, WistarReceptors, GABA-AReceptors, NicotinicXenopus laevisalpha7 Nicotinic Acetylcholine ReceptorChrna7 protein, ratGabra5 protein, ratIndolesLigand-Gated Ion ChannelsReceptors, GABA-AReceptors, Nicotinic

Identifiers

PMID21159751
PMCPMC3061525
OpenAlexW2136463432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.